Neurocrine Biosciences Inc (NBIX) reported earnings for fourth quarter that decreased from the same period last year and missed the Street estimates.
The company's bottom line came in at $103.1 million, or $1.00 per share. This compares with $147.7 million, or $1.44 per share, last year.
Excluding items, Neurocrine Biosciences Inc reported adjusted earnings of $173.4 million or $1.69 per share for the period.
Analysts on average had expected the company to earn $1.93 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 21.8% to $627.7 million from $515.2 million last year.
Neurocrine Biosciences Inc earnings at a glance (GAAP) :
-Earnings: $103.1 Mln. vs. $147.7 Mln. last year.
-EPS: $1.00 vs. $1.44 last year.
-Revenue: $627.7 Mln vs. $515.2 Mln last year.
For comments and feedback: editorial@rttnews.com